← Back
$CPRX All transactions

CATALYST PHARMACEUTICALS, INC.

M

$ Value

Shares

7,139

Price

Filed

Jan 6

Insider

Name

Kalb Michael Wayne

Title

Executive Vice President & CFO

CIK

0001678248

Roles

Officer

Transaction Details

Transaction Date

2026-01-05

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

15,745

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. | Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock. | Derivative securities vest in equal tranches, 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027, 1/5th on January 1, 2028, and 1/5th on January 1, 2029. | Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on January 5, 2026.

Filing Info

Accession No.

0001161697-26-000022

Form Type

4

Issuer CIK

0001369568

Kalb Michael Wayne's History

Date Ticker Type Value
2026-01-05 CPRX M
2026-01-05 CPRX F
2026-01-05 CPRX M $0
2025-11-21 CPRX M
2025-11-21 CPRX F
2025-11-21 CPRX M $0
2025-11-20 CPRX A $0
2025-11-20 CPRX A $0

Other Insiders at CPRX (90d)

Insider Bought Sold Last
Russo Gregg
Chief HR Officer
2026-02-17